Rickard Kathleen A.
Insider CIK 1836883 · VRNA Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRNA Verona Pharma plc | M Exercise deriv | 2025-10-07 | 2025-10-08 | 200,000 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-10-07 | 2025-10-08 | 167,056 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-10-07 | 2025-10-08 | 146,168 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | D To issuer deriv | 2025-10-07 | 2025-10-08 | 100,000 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | D To issuer deriv | 2025-10-07 | 2025-10-08 | 560,000 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-10-07 | 2025-10-08 | 618,760 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2025-10-07 | 2025-10-08 | 618,760 | — | $0 | 618,760 | SEC↗ |
| VRNA Verona Pharma plc | D To issuer | 2025-10-07 | 2025-10-08 | 1,131,984 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | D To issuer | 2025-10-07 | 2025-10-08 | 2,432,868 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-10-07 | 2025-10-08 | 1,131,984 | — | $0 | 1,131,984 | SEC↗ |
| VRNA Verona Pharma plc | G Gift | 2025-08-29 | 2025-09-03 | 189,600 | — | $0 | 2,417,872 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-08-01 | 2025-08-05 | 50,000 | — | $0 | 200,000 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-08-01 | 2025-08-05 | 20,888 | — | $0 | 146,168 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-08-01 | 2025-08-05 | 70,888 | — | $0 | 2,665,808 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-08-01 | 2025-08-05 | 58,336 | $13.14 | $766.5K | 2,607,472 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2025-07-08 | 2025-07-09 | 37,616 | $11.44 | $430.3K | 2,594,920 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2025-07-07 | 2025-07-09 | 253,120 | — | $0 | 253,120 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-07-07 | 2025-07-09 | 86,064 | — | $0 | 167,056 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-07-07 | 2025-07-09 | 86,064 | — | $0 | 2,632,536 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-05-06 | 2025-05-08 | 114,984 | $8.82 | $1.01M | 2,546,472 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-05-01 | 2025-05-05 | 50,000 | — | $0 | 250,000 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-05-01 | 2025-05-05 | 21,864 | $8.95 | $195.7K | 2,661,456 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-05-01 | 2025-05-05 | 27,336 | $8.95 | $244.7K | 2,633,320 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-05-01 | 2025-05-05 | 50,000 | — | $0 | 2,683,320 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2025-04-29 | 2025-05-01 | 253,120 | — | $0 | 253,120 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-04-29 | 2025-05-01 | 86,064 | — | $0 | 167,056 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-04-29 | 2025-05-01 | 34,384 | $8.98 | $308.8K | 2,660,656 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-04-29 | 2025-05-01 | 86,064 | — | $0 | 2,695,040 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-03-12 | 2025-03-13 | 79,264 | $8.35 | $661.9K | 2,608,976 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2025-02-03 | 2025-02-04 | 33,240 | $7.16 | $238.0K | 2,688,240 | SEC↗ |
| VRNA Verona Pharma plc | A Award | 2025-02-01 | 2025-02-04 | 50,000 | — | $0 | 2,721,480 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-11-25 | 2024-11-26 | 240,000 | $4.90 | $1.18M | 2,671,480 | SEC↗ |
| VRNA Verona Pharma plc | A Award | 2024-11-01 | 2024-11-01 | 50,000 | — | $0 | 2,977,416 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2024-11-01 | 2024-11-01 | 65,936 | $4.24 | $279.6K | 2,911,480 | SEC↗ |
| VRNA Verona Pharma plc | A Award | 2024-10-30 | 2024-11-01 | 300,000 | — | $0 | 2,927,416 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2024-08-07 | 2025-05-01 | 300,000 | — | $0 | 300,000 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2024-08-07 | 2024-08-09 | 87,904 | $2.62 | $230.3K | 2,627,416 | SEC↗ |
| VRNA Verona Pharma plc | A Award | 2024-08-07 | 2024-08-09 | 200,000 | — | $0 | 2,715,320 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2024-08-01 | 2024-08-05 | 106,232 | $2.83 | $300.6K | 2,515,320 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-05-03 | 2024-05-03 | 36,248 | $1.96 | $71.0K | 2,621,552 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2024-05-01 | 2024-05-03 | 73,824 | $1.93 | $142.5K | 2,657,800 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-02-05 | 2024-02-05 | 36,248 | $2.22 | $80.5K | 2,731,624 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2024-02-01 | 2024-02-05 | 72,768 | $2.29 | $166.6K | 2,767,872 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-11-03 | 2023-11-03 | 58,752 | $1.92 | $112.8K | 2,840,640 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2023-11-01 | 2023-11-03 | 173,136 | $1.74 | $301.3K | 2,899,392 | SEC↗ |
| VRNA Verona Pharma plc | A Award | 2023-10-20 | 2023-10-24 | 200,000 | — | $0 | 3,072,528 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-08-07 | 2023-08-07 | 1,600 | $2.47 | $4.0K | 2,872,528 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-08-04 | 2023-08-07 | 27,944 | $2.50 | $69.9K | 2,874,128 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-08-03 | 2023-08-07 | 28,752 | $2.55 | $73.3K | 2,923,920 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-08-03 | 2023-08-07 | 21,848 | $2.54 | $55.5K | 2,902,072 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-08-02 | 2023-08-03 | 13,728 | $2.59 | $35.6K | 2,952,672 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-08-01 | 2023-08-03 | 19,736 | $2.68 | $52.9K | 2,966,400 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-05-03 | 2023-05-03 | 28,752 | $2.65 | $76.2K | 2,971,136 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2023-05-01 | 2023-05-11 | 15,000 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-05-01 | 2023-05-03 | 77,424 | $2.58 | $199.8K | 2,999,888 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2023-05-01 | 2023-05-11 | 15,000 | — | $0 | 2,986,136 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-02-02 | 2023-02-03 | 28,752 | $2.53 | $72.7K | 3,077,312 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-02-01 | 2023-02-03 | 89,960 | $2.56 | $230.3K | 3,106,064 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2023-01-20 | 2023-02-03 | 105,000 | — | $0 | 15,000 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2023-01-20 | 2023-02-03 | 105,000 | — | $0 | 3,196,024 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2022-11-01 | 2022-11-03 | 28,752 | $1.64 | $47.2K | 3,091,024 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2022-11-01 | 2022-11-03 | 56,264 | $1.60 | $90.0K | 3,119,776 | SEC↗ |
| VRNA Verona Pharma plc | A Award | 2022-09-26 | 2022-09-28 | 800,000 | — | $0 | 3,176,040 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2022-08-02 | 2022-08-03 | 28,752 | $0.70 | $20.1K | 2,376,040 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2022-08-01 | 2022-08-03 | 56,432 | $0.67 | $37.8K | 2,404,792 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2022-05-03 | 2022-05-05 | 28,752 | $0.49 | $14.1K | 2,461,224 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2022-05-01 | 2022-05-03 | 56,432 | $0.52 | $29.3K | 2,489,976 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2022-04-11 | 2022-04-12 | 59,720 | $0.54 | $32.2K | 2,546,408 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2022-04-08 | 2022-04-12 | 112,800 | $0.59 | $66.6K | 2,606,128 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2022-02-01 | 2022-02-03 | 63,560 | $0.78 | $49.6K | 2,718,928 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2021-11-01 | 2021-11-03 | 56,928 | $0.64 | $36.4K | 2,782,488 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2021-08-01 | 2021-08-03 | 227,736 | $0.79 | $179.9K | 2,839,416 | SEC↗ |